Dali Pharmaceutical Co Ltd

603963

Company Profile

  • Business description

    Dali Pharmaceutical Co Ltd operates in the pharmaceutical manufacturing industry. It is engaged in the research and development and production of Chinese and Western medicine injection products. The company's main products are Zhongjing Brand Xingnaojing Injection, Shenmai Injection, Astragalus Injection, Brighten A Injection and Cell Diphosphocholine injection.

  • Contact

    No. 118, Huancheng West Road
    Yunnan Province
    Xiaguan Town
    Dali671000
    CHN

    T: +86 8728880055

    http://www.daliyaoye.cn

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - Specialty & Generic

    Fiscal Year End

    31 December 2024

    Employees

    272

Stocks News & Analysis

stocks

Undervalued ASX share hampered by delays in foreign expansion

A near monopoly in Australia pushes this company into global markets but progress has been slow.
stocks

Ask the analyst: Why has MinRes fallen so far?

Mineral Resources shares are down almost 50% year to date. Mark Taylor weighs in on some of the reasons why.
stocks

The largest ASX company is materially overvalued

After a 37% share price increase in the last 12 months, investors may be too optimistic for this ASX giant 

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,518.9033.70-0.39%
CAC 407,426.8888.211.20%
DAX 4019,448.60233.121.21%
Dow JONES (US)44,318.84329.850.75%
FTSE 1008,125.1952.800.65%
HKSE20,426.93301.26-1.45%
NASDAQ19,264.0022.78-0.12%
Nikkei 22539,533.3232.950.08%
NZX 50 Index12,686.3384.00-0.66%
S&P 5005,997.582.040.03%
S&P/ASX 2008,266.2028.90-0.35%
SSE Composite Index3,470.0717.770.51%

Market Movers